MarketInOut Stock Screener Log In | Sign Up

AbbVie Inc

XETRA • Healthcare • Drug Manufacturers - General • Quote as of 10/28/2026 09:23
AbbVie Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeXETRA
Market Capitalization449,555 mln
Float1,765 mln
Earnings Date10/29/2026

EPS

3.03
Stretched

P / E

83.76
Speculative

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.86
Likely reliable

Relative Strength

69 / 100
Outperforming

Pre-Tax Margin

14%
Moderate margin

Business Description

AbbVie is a global medicines company that develops, manufactures, and sells treatments across a wide range of health conditions, including cancer, autoimmune and inflammatory diseases, neurological disorders, and eye care. Its portfolio includes well-known products such as Skyrizi, Rinvoq, Imbruvica, and Botox, among many others. Founded in 2012 and based in North Chicago, Illinois, the company operates worldwide and continues to invest heavily in research to bring new therapies to patients.

Key Fundamentals

EPS3.03
P/E83.76
ROE-136
RPS32.43
ROIC14.21
ROA4.66
Interest Cover7.13
EBITDA, mln16,898
EV / EBITDA26.94
EV / EBIT45.02
Revenue, mln55,213
EV / Revenue8.24

Quote Details

Last 256.00
Change -0.6 (-0.23%)
Open 253.80
Volume 103
Turnover 26,368
Average Volume 972.71

Financial Ratios

Pre-Tax Profit Margin14
Current Ratio0.81
Price / Cash Flow25.93
Price / Free Cash Flow25.65
Price / Sales7.26
PEG Ratio0.58

Financial Strength

Altman Z-Score2.49
Piotroski F-Score 8 / 9
Beneish M-Score-2.86
Price to Intrinsic Value2.58
Shiller PE Ratio54.66

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.39% 81 / 100   
1 Month 10.87% 93 / 100   
2 Months 13.05% 91 / 100   
6 Months 46.52% 97 / 100   
1 Year 35.64% 90 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog